Vector Laboratories Awards Exclusive Canadian Distributorship to MJSBioLynx
Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, announced today that it has selected Brockville, Ontario-based MJSBioLynx as its exclusive distributor in Canada. MJSBioLynx specializes in providing high-quality products for life science researchers in protein chemistry, immunology, molecular biology and microbiology.
Vector Laboratories has been active in the Canadian market for more than 20 years. “We made the move to MJSBioLynx because they have such a strong network of technical field salespeople, bi-lingual staff and a track record of success throughout Canada,” said Ravi Vinayak, Ph.D., general manager of global channel distribution for Maravai lifesciences. “With this agreement, we are well positioned to serve customers in all parts of Canada.
“We are pleased to add Vector Laboratories’ large portfolio of products to our offerings,” said Cherin McKend, president of MJSBioLynx. “We have been building our relationships and track record, in conjunction with our sister company, Chromatographic Specialties, for more than 50 years, and the Vector Laboratories products are in strong demand by our customers.”
About Vector Laboratories
Vector Laboratories develops, manufactures and markets labeling and detection reagents for immunohistochemistry, immunofluorescence, DNA/RNA and glycobiology. The company serves customers in disease and therapeutics research with tools that help them precisely visualize and study tissues and cells. A pioneer in a number of innovative technologies, Vector Laboratories has been providing a continuous stream of reliable tools to its customers for more than 40 years. With headquarters in Burlingame, California and a subsidiary in Peterborough, U.K., the company maintains a network of more than 40 distributors across the globe. A privately held company, Vector Laboratories was acquired by Maravai LifeSciences in 2016.
Contacts for the media:
David Weber, Chief Commercial Officer